IRITEC

Concentrate for solution for infusion, 40mg/2ml

RxActive license

Active substance (INN)

irinotecan

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion

Strength40mg/2ml

PackagingUkupno 1 bočica staklena sa 2ml koncentrata za rastvor za infuziju u kartonskoj kutiji

ManufacturerVianex S.A. - Plant C, Greece

Therapeutic groupAntineoplastic and immunomodulating agents (L01CE02)

Marketing authorization holder"OSMI RED-D" D.O.O. PODGORICA

Authorization dateNovember 25, 2025

Analogs in Montenegro

7

Other medicines with the same active substance

IRINOTECAN ACCORDRx

Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera

IRINOTECAN ACCORDRx

Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera

IRINOTECAN ACCORDRx

Concentrate for solution for infusion, 20mg/mlAccord Healthcare Polska Sp. z o.o. Magazyn Importera

IRINOTECAN QILURx

Concentrate for solution for infusion, 40mg/2mlKymos

IRINOTECAN QILURx

Concentrate for solution for infusion, 100mg/5mlKymos

Concentrate for solution for infusion, 100mg/5mlVianex S.A. - Plant C

ONIVYDE PEGYLATED LIPOSOMALRx

Concentrate for dispersion for infusion, 4.3mg/mlLes Laboratoires Servier Industrie

Source: CInMED register